[ORGANIZATION]
Awiqli (insulin icodec‑abae)
Featured in 1 tracked story · first seen
Situations
Global rollout of once‑weekly insulin
2 clusters · 2 sources · last updated
Latest: Insulin Options Expand: OTC Regular and Once‑Weekly Formulations
Novo Nordisk’s insulin icodec‑abae, marketed as Awiqli, received US FDA approval in March 2026 as the first once‑weekly formulation for adults with type 2 diabetes. By early July the product was launched in India, extend